(Date:11/20/2009)...ings in children with chronic kidney disease often... office visits increasing a child,s risk for seri...ns Hopkins Children,s Center and other institution...Journal of American Society of Nephrology. , R...tained during regular doctor visits to readings ob...
(Date:11/20/2009)...severe cases than with seasonal flu , ,...archers are reporting that children with asthma ar...than seasonal flu. , "Asthma has been identifie...pandemic H1N1 influenza, present in 21 percent to ... Allen and fellow researchers from the Hospital fo...
(Date:11/20/2009)...W, Calif., Nov. 20 Omnic...ystem solutions to acute healthcare facilities, an...t Annual Piper Jaffray Healthcare Conference at t...mnicell Speakers: Randall A. Lipps, founder, chai...dent & CFO ,, Date: Tuesday, December 1, ...
(Date:11/20/2009)... Nov. 20 The US governm...ruggled to get enough food to eat. This startling...ults who are rapidly aging into poverty. "Forced ... divorce mean many have incomes that no longer cov...e. Older women are particularly vulnerable," said...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Oncology Roadmap: Brand Spe..., http://www.reportlinker.com/p0164998/Oncology-...ast-to-2013.html#utm_source=prnewswire&utm_med...ensive Forecasts and Detailed Budget Benchmarks ne...
Breaking Medicine News(10 mins):Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 2Health News:Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 3...ls Encourage Healthier Living on Your Own Terms, ...at,your current health could hamper your hopes for...the American Hospital Association estimates that,m...ges can improve your quality of life for years to ...
...rmuda, Jan. 7 Warner Chilcott,Limited (Nasdaq: W...26th,Annual JPMorgan Healthcare Conference on Wedn...rd Time. Presenting for Warner Chilcott will be Pa...t Warner Chilcott,s Investor Relations website at,...
... per cent of men who are circumcised can enjoy the...e as men who are not, according to a study of near...he UK-based urology journal BJU International. , ...now recommended as an efficient way to reduce HIV ...
...nts are significantly less likely than their white... of cancer, despite recent efforts to close gaps i...t Yale School of Medicine published in the January... professor of medicine at Yale School of Medicine,...
...od(R) Personal Diabetes Manager to Integrate DexCo...hnology, BEDFORD, Mass. and SAN DIEGO, Jan. 7 In...wearable insulin pump technology,with its OmniPod(...nnounced today they have signed a development,agre...
...Md. and MCLEAN, Va., Jan. 7 -,A USA TODAY/ Discove...n,addition to diet and exercise, friends and famil...eight and maintain health lifestyle habits., Key ...een a hindrance in their attempts to lose weight, ...
Other Medicine News:Health News:For Healthier Lifestyles That Can Be Habit-Forming, Take the Meals Matter Nutrition & Fitness Challenge! 2Health News:For Healthier Lifestyles That Can Be Habit-Forming, Take the Meals Matter Nutrition & Fitness Challenge! 3Health News:Circumcision doesn't reduce sexual satisfaction and performance, says study of 4,500 men 2Health News:Despite efforts, significant racial disparities in cancer therapy still exist 2Health News:Insulet Corporation and DexCom Announce Development Agreement 2Health News:Insulet Corporation and DexCom Announce Development Agreement 3Health News:Insulet Corporation and DexCom Announce Development Agreement 4Health News:Insulet Corporation and DexCom Announce Development Agreement 5Health News:Insulet Corporation and DexCom Announce Development Agreement 6Health News:New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 2Health News:New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 3(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstC... BDX ) today announced the completion of its acqu...based company that develops and manufactures molec..., In May 2009, BD and HandyLab announced an exc...ze molecular assays on the HandyLab Jaguar(TM) pla...
(Date:11/20/2009)..., PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall...oligenix or the Company), formerly known as DOR Bi... announced today that it has formed a consortium t...(TM) and other rapidly acting vaccines. Soligenix ...stitute of Allergy and Infectious Diseases (NIAID)...
(Date:11/19/2009)..., BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCal...X ) today announced the pricing of a public offeri...5 per share, resulting in gross proceeds of $48.75...BioCryst pursuant to an effective shelf registrati...and Exchange Commission. BioCryst has also grante...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Essentialis to Submit SPA for Hypertriglyceridemia 4847 1Essentialis to Submit SPA for Hypertriglyceridemia 4847 2West to Present at the Ninth Annual CJS Securities New Ideas Summer Conference 54267 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 33SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 43SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 53SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 63SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 73SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 83SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 93SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 103SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 113SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 123SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 133SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 143SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 153SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 163SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 173SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 183SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 193SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 203SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 213SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 223SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 233SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 243SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 25...opment Program in Multiple Myeloma, SOUTH SAN FRA...ounced that patient dosing has commenced in a Phas...icacy of Proteolix,s lead anti-cancer,agent, carfi...and,dexamethasone in patients with relapsed multip...ome activity, causing apoptosis in cancer cells.,I...
...Pharmaceuticals, Inc. (Nasdaq: BCRX ) today annou...scular (i.m.) peramivir for the treatment of,seaso...led, parallel group Phase II trial,will compare th...ramivir to,placebo in the treatment of seasonal in...sis of a recently completed Phase I study of a new...
Other Medicine Technology:Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma 2Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma 3BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza 2BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza 3BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza 4BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
...articulation maintains full inter-changeability. M...tions for better patient fit. The Maxim Knee syst...epts with expanded options to address surgeon pref...or use in total knee replacements both in primary ...
...erchangeability between femoral and tibial compone...ibial component with a durable cobalt chrome femor...GC® Knee is indicated for use in total knee re...ions are required. Unique Cam-and-Groove Posterior...
...laser combines excellent cutting, ablation and coa...ss procedures. It is also extremely effective in f...compositions, making it an ideal multipurpose surg...through flexible fibers, it is especially suited f...
Medicine Products: